Form 4 for XYL Xylem Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001524472-26-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-03-01+ | XYL | Yarkadas Hayati | EVP, Pres, WI | A - Grant | $108.99 | +14.7K | 34.4K | +75% | +$1.60M |
| DM | 2026-03-03 | 2026-03-02 | XYL | Yarkadas Hayati | EVP, Pres, WI | F - Tax | $128.98 | -776 | 33.7K | -2% | -$100.1K |
| D | 2026-03-03 | 2026-03-02 | XYL | Yarkadas Hayati | EVP, Pres, WI | A - Grant | $128.98 | +8,102 | 8,102 | New | +$1.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | A | A | 3,679 | $128.98 | 27,821 | D | — | — | (F3) Reflects the acquisition of 3,679 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. |
| 2 | Common | Common Stock | 2026-03-01 | A | A | 2,501 | $128.98 | 30,322 | D | — | — | (F4) Reflects the acquisition of 2,501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. |
| 3 | Common | Common Stock | 2026-03-01 | A | A | 1,761 | $128.98 | 32,083 | D | — | — | (F5) Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. |
| 4 | Common | Common Stock | 2026-03-01 | A | A | 4,456 | $128.98 | 24,142 | D | — | — | (F1) Reflects the acquisition of 4,456 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. (F2) Includes additional shares due to dividend reinvestment. |
| 5 | Common | Common Stock | 2026-03-02 | F | D | 117 | $128.98 | 33,581 | D | — | — | (F9) Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (75) and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). |
| 6 | Common | Common Stock | 2026-03-02 | F | D | 565 | $128.98 | 33,792 | D | — | — | (F7) Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). |
| 7 | Common | Common Stock | 2026-03-02 | A | A | 2,274 | $0.00 | 34,357 | D | — | — | (F6) Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. |
| 8 | Common | Common Stock | 2026-03-02 | F | D | 94 | $128.98 | 33,698 | D | — | — | (F8) Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). |
| 9 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-03-02 | A | A | 8,102 | $128.98 | 8,102 | D | $128.98 · — to 2036-03-02 | 8,102 Common Stock | (F10) Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. |